CTIS2024-511196-15-00进行中（未招募）1 期
PHA022121-C020
Pharvaris Netherlands B.V.0 个研究点目标入组 14 人开始时间: 2024年3月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet administered once daily on the pharmacokinetics of the P-gp substrate digoxin and the BCRP substrate rosuvastatin, administered as a drug cocktailHereditary angioedemaCTIS2024-514713-35-0014
招募中
1 期
A Phase I study to evaluate the safety and dosimetry of 68Ga-labelled OncoFAP derivatives in patients with solid tumorsPatients with breast cancer, colorectal cancer, oesophageal cancer and pancreatic adenocarcinoma.MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2022-500902-16-00Philogen S.p.A.20
招募中
1 期
Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM534 Administered Intravenously to Patients with Advanced Solid TumorsAdvanced Solid TumorsCTIS2024-513056-15-00Pharma Mar S.A.30
进行中（未招募）
1 期
A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochemical Recurrence after Definitive Local Therapy for Prostate CancerProstate CancerCTIS2023-504066-39-00Vaccitech PLC117
进行中（未招募）
1 期
Randomised, crossover bioavailability clinical trial of oral minoxidil 1 mg, after single and multiple dose administration to healthy volunteers under fasting conditionsAndrogenetic alopeciaCTIS2023-503796-14-00Industrial Farmaceutica Cantabria S.A.14